Mechanistically, SDX-7320-mediated tumor growth inhibition likely results from both direct anti-tumor effects (given the observed intratumoral changes in the expression of cell cycle and immune response genes), and indirect effects on the host including weight loss, decreased adipose mass, improved insulin sensitivity and normalization of plasma leptin and adiponectin levels. The gene discussed is LEP; the disease is neoplasm.